Sign in

You're signed outSign in or to get full access.

Edwin B. Moran

President at Omega Flex
Executive
Board

About Edwin B. Moran

Edwin B. Moran (age 58) is President of Omega Flex, Inc. and a Class 2 director since January 1, 2024; he has 30+ years of industry experience in flexible metal hose products, including leadership of sales and marketing and now operations and sales . Company performance context: 2023 net sales were $111.465M (−11.2% YoY), net income $20.763M, and EBIT $25.845M; five‑year TSR was 142.20% vs S&P 500 207.21% and S&P Building Products 274.41% . Moran was part of a planned succession with separation of Executive Chairman (Hoben), CEO (Rivest) and President (Moran), with lead independent director oversight .

Past Roles

OrganizationRoleYearsStrategic Impact
Omega Flex, Inc.President2024–present Leads operations and sales; part of succession plan strengthening execution
Omega Flex, Inc.Executive Vice President2022–2023 Led all sales and marketing except MediTrac; helped drive commercial strategy
Omega Flex, Inc.Vice President – Sales Residential Markets2007–2021 Scaled residential gas piping sales for TracPipe/CounterStrike portfolio
Omega Flex, Inc.Various sales roles2001–2006 Progression through sales/distribution roles building market presence

External Roles

OrganizationRoleYearsStrategic Impact
Flex‑Trac, Inc. (OFLX subsidiary)Director2024–present Governance of MediTrac medical gas piping business; equity incentive grants align performance

Fixed Compensation

Metric20232024
Base Salary ($)$400,000 $540,800
Cash Bonus/Non‑Equity Incentive ($)$270,000 $225,000
All Other Compensation ($)$33,754 $30,935

Notes:

  • All other compensation includes profit sharing contributions and dividend equivalents on phantom units .
  • As of April 1, 2024, NEO base salaries included Moran at $540,800 .

Performance Compensation

Award TypeMetricGrant/PeriodTargetActual/PayoutVesting
Executive Incentive Plan (cash)EBITFY2023 (pool 10.2% of EBIT) Not disclosed$270,000 payout Annual cash; no vesting
Executive Incentive Plan (cash)EBITFY2024 (pool % reduced to 6.0%) Not disclosed$225,000 payout Annual cash; no vesting
Phantom Stock Units (cash‑settled)TSR/Stock PriceMar 8, 2023: 667 units; grant FV $74,964 at $112.39 N/APays full value at maturity one year after vesting 3‑year vest; cliff vest at 3 years (post‑2023 grants), maturity 1 year after vest
Phantom Stock Units (cash‑settled)TSR/Stock PriceMar 20, 2024: 1,042 units; grant FV $75,000 at $72.00 N/AAs above 3‑year cliff vest; dividend equivalents accrue, paid only if vested
Flex‑Trac Restricted StockSubsidiary equity performanceJan 2, 2025: 80,000 shares N/AN/A (restricted shares) Full vest on Dec 31, 2032, or earlier upon change in control or death/disability/retirement; forfeited if shareholder approval not obtained

Design features:

  • EIP metric is EBIT, reflecting focus on operating performance of continuing ops .
  • Phantom units are non‑dilutive and cash‑settled, aligning with TSR while avoiding share issuance .
  • Flex‑Trac awards include double‑trigger vesting upon change in control if replacement awards are provided .

Equity Ownership & Alignment

Ownership Item20242025
OFLX common shares beneficially owned0 215 (401(k) plan fund)
OFLX ownership % of outstanding~0.000% ~0.002% (215/10,094,322)
Flex‑Trac restricted stock held80,000 (subject to plan approval; vest conditions per plan)
Flex‑Trac ownership % of outstanding~0.76% (80,000/10,514,322)
Phantom stock units unvested at FY‑end1,130 units ($79,699 MV) 1,874 units ($78,637 MV)
Units matured in year (vested prior grants)930 units; $114,669 value realized (maturity)

Alignment controls and practices:

  • Pledging of OFLX stock by NEOs/directors is prohibited without board approval; hedging policy not specified .
  • Insider trading blackout applies quarterly to directors/officers .
  • Clawback policy adopted per SEC/Nasdaq rules; executives have acknowledged compliance .

Employment Terms

ProvisionKey Terms
Change‑of‑Control AgreementPost‑CoC employment period 3 years; same position/duties/location; base ≥ highest pre‑CoC year; may elect 3‑year average bonus paid monthly in lieu of plan participation; continued benefits on most favorable terms in prior 120 days
Termination (post‑CoC)If terminated other than death/disability/retirement or resigns for Good Reason: cash severance = 2×(base salary + average of last two annual bonuses); 12 months of continued benefits
Termination (pre‑CoC)If terminated other than death/disability/for cause: 18 months base salary, continuation of all benefits, and participation in executive incentive plan through next annual payout; extension of any option exercise windows (if applicable)
Good Reason / Cause definitionsDetailed definitions including diminution of duties, failure to pay, relocation >35 miles; Cause includes deliberate misconduct, failure to perform after notice, felony, controlled substance abuse, material breach
Potential Payments (illustrative)As of Dec 31: Without Cause/Good Reason/Non‑Renewal: $870,000 (2023) ; $1,036,200 (2024) . Termination after Change in Control: $1,329,798 (2023) ; $1,576,600 (2024) . Benefits continuation adds one year medical .
Tax treatmentNo excise tax gross‑ups; payments reduced to avoid §4999 excise tax; §409A compliance

Board Governance

  • Board service: Class 2 director since Jan 1, 2024; nominated for term to 2028 .
  • Committee roles: None; employee directors do not receive separate director compensation .
  • Independence: Not independent (management); board independence maintained via lead independent director and independent committees .
  • Attendance: Board met 6 times in 2024; all directors present at all meetings; independent directors held executive sessions at 4 meetings . In 2023, 4 meetings; all directors met attendance thresholds .
  • Lead Independent Director: J. Nicholas Filler; audit chair and designated lead .

Director Compensation (for employee directors)

  • Employee directors (including Moran) receive no separate cash or equity director compensation; non‑employee director fee program exists (e.g., annual retainer $90,000, committee chair $5,512 in 2024/2025) but does not apply to Moran .

Compensation Peer Group and Say‑on‑Pay

  • Peer group (12 industrial companies; $100M–$500M sales) used to benchmark executive compensation; OFLX performance exceeded medians in returns on equity/investment/assets (below median in sales and cash flow) .
  • 2023 Say‑on‑Pay approval: 99.62% of votes cast; 88.28% of outstanding shares supported NEO compensation .
  • 2025 advisory votes: Say‑on‑Pay and frequency proposal; board recommends “three years” frequency .

Risk Indicators & Red Flags

  • Clawback policy adopted per SEC/Nasdaq (positive alignment) .
  • Pledging: Prohibited without board approval (alignment safeguard) .
  • Related party transactions: None reportable in 2023/2024 (other than status of major shareholder Mr. Reed) .
  • Legal/disciplinary: No director bankruptcy/insolvency or criminal convictions/pending proceedings in past 10 years .

Compensation Structure Analysis

  • Mix shift: Moran’s base rose from $400k (2023) to $540.8k (2024), while cash bonus declined ($270k → $225k), and ongoing phantom unit grants continued ($74,964 → $75,000 grant FV); net effect is slightly higher fixed pay, with continued at‑risk cash and market‑linked long‑term incentives .
  • Equity vehicle: Continued use of cash‑settled phantom units (non‑dilutive) aligns with TSR while limiting share issuance; dividend equivalents accrue only if vested (disciplined long‑term focus) .
  • New subsidiary equity: 80,000 Flex‑Trac restricted shares vest in 2032 or earlier on qualified events; awards carry double‑trigger change‑in‑control protections and clawback coverage (retention and performance orientation) .

Investment Implications

  • Alignment: Moran’s incentive pay is tightly linked to EBIT and TSR via the executive incentive plan and phantom stock units; clawback and insider trading controls add governance discipline .
  • Selling pressure: Minimal direct OFLX shareholdings (≈0.002% of outstanding) and non‑dilutive phantom units suggest low insider selling pressure from Moran; Flex‑Trac grants are subsidiary equity with long‑dated vesting .
  • Retention and CoC economics: Strong retention via phantom units’ vesting/maturity and meaningful CoC severance (2× salary + average bonus) with 12 months benefits; pre‑CoC severance provides 18 months salary/benefits—reduces transition risk but creates potential payout obligations under strategic scenarios .
  • Governance: Dual role (President + director) is balanced by separated Chairman/CEO roles and lead independent oversight; no committee assignments reduce potential conflicts, and board independence is reaffirmed annually .

Key levers to monitor: annual EBIT trajectory (bonus pool), phantom unit vesting/maturity schedules and accrued amounts, progress and economics of Flex‑Trac/MediTrac, and any changes to CoC agreements or subsidiary equity plans .